What SigmaStim does

SigmaStim, headquartered in the Portland, Oregon area (Tualatin), is a privately held medical device manufacturer specializing in electroconvulsive therapy (ECT) systems. The company produces the Σigma ECT Device, a controlled-electrical-pulse system used under anesthesia to induce therapeutic seizures for the treatment of severe psychiatric conditions including treatment-resistant major depression, bipolar disorder, psychotic illnesses such as schizophrenia, catatonia, and epilepsy. The device integrates physiological monitoring capabilities (EEG, ECG, EMG, blood pressure, and O2 saturation), built-in electrode placement configurations, and printable biomedical and error log reports. The product line is complemented by a Σigma Starter Kit for new customers, optional accessories, Σigma EMR Software for clinical documentation, and clinician instructional materials.

The company sells exclusively to licensed healthcare providers and hospitals in the US and Canada through a direct enterprise sales motion (phone, email, same-business-day response), while international customers are served through a network of local distributors. Revenue streams consist of one-time device and software license sales, hardware accessories, and training and education revenue through the International Course on Electroconvulsive Therapy, which features expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

SigmaStim operates through two LLC entities — SigmaStim Domestic LLC for US sales and SigmaStim International LLC for international sales — and is owned by Balance Point LLC, with no disclosed external investors or venture funding. The company maintains FDA clearance for its device and its Patients and Families Information Booklet, and operates with 11–50 employees. There is no evidence of recent M&A, leadership changes, or material strategic repositioning in the available source material.

Name

SigmaStim

Legal name

SigmaStim

Website

https://sigmastim.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

SigmaStim is a privately held Oregon-based medical device manufacturer that sells the FDA-cleared Σigma electroconvulsive therapy (ECT) system, EMR software, accessories, and clinician training exclusively to licensed healthcare providers and hospitals in the US, Canada, and internationally via distributors.

Ownership category

akta.pro rank

Product category

Electroconvulsive Therapy Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Electrophysiology Mapping & Ablation Systems (HLAHAFAD)

akta.pro secondary industries

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE), EHR Implementation, Optimization, Training & Managed Services (HLACAAAL)

Keywords

• Electroconvulsive therapy devices
• ECT medical devices
• Psychiatric treatment equipment
• Medical device manufacturing
• EMR software psychiatry

Headquarters

HQ city

Tualatin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. ECT Device Sales: Sale of Σigma ECT devices to licensed healthcare providers and hospitals. This is the primary revenue stream for the company.
2. EMR Software: Sale of SigmaStim EMR software for ECT documentation and clinical records management.
3. Accessories and Consumables: Sale of Σigma ECT accessories and optional add-ons for the device system.
4. Training and Education: The company offers the International Course on Electroconvulsive Therapy with individual lecture purchases and full course bundles. Includes PDF presentation slides and exclusive Q&A recordings. Faculty includes Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

SigmaStim manufactures and sells the Σigma (Sigma) Electroconvulsive Therapy (ECT) device system — a FDA-cleared medical device that delivers controlled electrical pulses under anesthesia to treat severe psychiatric conditions such as treatment-resistant major depression, bipolar disorder, schizophrenia, catatonia, and epilepsy. The integrated system includes proprietary electrical dosing control, configurable electrode placement, multi-parameter physiological monitoring (EEG, ECG, EMG, BP, O2), and Σigma EMR software for ECT-specific clinical documentation. The company also supplies accessories, a starter kit, clinician instructional materials, and paid training through the International Course on ECT.

Product overview

SigmaStim offers the ΣIGMA line of electroconvulsive therapy (ECT) medical devices and related products. The core product is the ΣIGMA ECT DEVICE, which is complemented by a STARTER KIT for new purchases, optional ACCESSORIES for ongoing clinical use, EMR SOFTWARE for electronic medical records integration, and INSTRUCTIONAL MATERIALS for clinician training. The company sells exclusively to licensed health providers and hospitals and does not provide direct services to patients.

Differentiator

Problem solved

Functional benefit

Brands

• Σigma ECT Device: The primary electroconvulsive therapy device product line sold by SigmaStim.
• Σigma EMR Software
• Σigma Starter Kit

Products and services

• ΣIGMA ECT Device The primary electroconvulsive therapy (ECT) device manufactured by SigmaStim, used by licensed healthcare providers and hospitals to deliver controlled electrical pulses under anesthesia to induce therapeutic seizures for treating severe psychiatric disorders including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. Features proprietary electrical dosing control, configurable electrode placement, and built-in physiological monitoring covering EEG, ECG, EMG, blood pressure, and oxygen saturation, plus printable Biomedical Reports and Error Logs.
• ΣIGMA Starter Kit A bundled starting package offered to clinicians and hospitals purchasing the Σigma ECT device, providing essential accessories and materials needed to begin using the device in a clinical ECT program.
• ΣIGMA Accessories Optional accessories, replacement parts, and supplementary consumable components sold separately for ongoing clinical use of the Σigma ECT device.
• ΣIGMA EMR Software Electronic Medical Records software designed to integrate with the Σigma ECT device, providing ECT-specific clinical documentation, treatment-course records, and workflow management for clinicians and hospitals administering ECT.
• International Course on Electroconvulsive Therapy Paid online training course on electroconvulsive therapy for clinicians, featuring expert faculty including Dr. Harold Sackeim, Dr. Colleen Loo, and Dr. William Vaughn McCall, sold via individual lecture purchases and full course bundles.

Quantifiable outcome

• High remission rate for major depression
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Medtronic: Medtronic's Neuromodulation division offers DBS and other stimulation platforms for neurological and psychiatric conditions, providing a broad incumbent competitor with significantly greater R&D and commercial scale than SigmaStim.
• LivaNova: LivaNova (formerly Cyberonics) markets vagus nerve stimulation (VNS) therapy for treatment-resistant depression, overlapping with ECT in indication and competing for the same specialist prescriber audience as part of a broader neuromodulation portfolio.
• Abbott: Abbott operates a broad neuromodulation business (including deep brain stimulation and spinal cord stimulation) that addresses psychiatric and neurological disorders, competing for hospital neuromoduation budgets that may otherwise be allocated to ECT.

Emerging players

• Neuronetics: Neuronetics commercializes NeuroStar TMS systems for treatment-resistant depression, an alternative neuromodulation modality competing for the same clinical indications and psychiatrist prescribing decisions as ECT.
• NeuroPace: NeuroPace develops the RNS System, a responsive neurostimulation device for epilepsy. While focused on seizure disorders rather than depression, it represents an adjacent implantable neurotechnology competitor that shares neuroscience research overlap with ECT.
• Brainsway: Brainsway develops deep TMS systems for depression and other psychiatric and neurological conditions, positioning itself as a less invasive alternative to ECT for treatment-resistant patients.
• Magstim: Magstim supplies transcranial magnetic stimulation systems and research-grade neurostimulation equipment used in both clinical psychiatry and neuroscience research, competing indirectly with ECT for treatment-resistant depression cases.
• Soterix Medical: Soterix Medical develops transcranial direct current stimulation (tDCS) and other non-invasive brain stimulation systems, providing another less invasive alternative to ECT that competes for psychiatric and neurological research and clinical adoption.

Direct peers

• Somatics LLC: Somatics manufactures the Thymatron line of ECT devices, the other principal ECT equipment brand used in U.S. psychiatric hospitals. It is a direct competitor to SigmaStim on device specifications, dosing algorithms, and clinical training.
• MECTA Corporation: MECTA is one of the longest-established U.S. manufacturers of ECT devices and is closely associated with the SigmaStim product lineage referenced in the company's data. It competes head-to-head in the same narrow ECT device category with similar clinical positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SigmaStim